Advanced search
Publication Cover
Clinical Ophthalmology Volume 16, 2022 - Issue
Submit an article Journal homepage
176
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)

Keyvan Koushan1 Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada;2 Toronto Retina Institute, Toronto, Ontario, CanadaCorrespondence[email protected]
View further author information
,
Arshia Eshtiaghi3 Faculty of Medicine, University of Toronto, Toronto, Ontario, CanadaView further author information
,
Pauline Fung2 Toronto Retina Institute, Toronto, Ontario, CanadaView further author information
,
Alan R Berger1 Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada;2 Toronto Retina Institute, Toronto, Ontario, CanadaView further author information
&
David R Chow1 Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada;2 Toronto Retina Institute, Toronto, Ontario, CanadaView further author information
Pages 1109-1115 | Published online: 08 Apr 2022

References

  • Romero-Aroca P. Managing diabetic macular edema: the leading cause of diabetes blindness. World J Diabetes. 2011;2:98. doi:10.4239/wjd.v2.i6.98
  • Korobelnik JF, Do DV, Schmidt-Erfurth U, et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121:2247–2254. doi:10.1016/j.ophtha.2014.05.006
  • Brown DM, Nguyen QD, Marcus DM, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two Phase III trials: RISE and RIDE. Ophthalmology. 2013;120:2013–2022. doi:10.1016/j.ophtha.2013.02.034
  • Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology. 2014;121:1045–1053. doi:10.1016/j.ophtha.2013.11.041
  • Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter Phase II study. Diabetes Care. 2010;33:2399–2405. doi:10.2337/dc10-0493
  • Elman MJ, Ayala A, Bressler NM, et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. Ophthalmology. 2015;122:375–381. doi:10.1016/j.ophtha.2014.08.047
  • Friberg TR, Karatza EC. Treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology. 1997;104:2030–2038. doi:10.1016/S0161-6420(97)30061-X
  • Scholz P, Altay L, Fauser S. A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders. Adv Ther. 2017;34:1528–1555. doi:10.1007/s12325-017-0559-y
  • Sivaprasad S, Elagouz M, McHugh D, Shona O, Dorin G. Micropulsed Diode Laser Therapy: evolution and Clinical Applications. Surv Ophthalmol. 2010;55:516–530. doi:10.1016/j.survophthal.2010.02.005
  • Laursen ML, Moeller F, Sander B, Sjoelie AK. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol. 2004;88:1173–1179. doi:10.1136/bjo.2003.040949
  • Inagaki K, Ohkoshi K, Ohde S, Deshpande GA, Ebihara N, Murakami A. Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561–577-nm) direct photocoagulation for diabetic macular edema. Jpn J Ophthalmol. 2015;59:21–28. doi:10.1007/s10384-014-0361-1
  • Mansouri A, Sampat KM, Malik KJ, Steiner JN, Glaser BM. Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness. Eye. 2014;28:1418–1424. doi:10.1038/eye.2014.264
  • Kwon YH, Lee DK, Kwon OW. The short-term efficacy of subthreshold Micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema. Korean J Ophthalmol. 2014;28:379. doi:10.3341/kjo.2014.28.5.379
  • Luttrull JK, Sinclair SH. Safety of transfoveal subthreshold diode micropulse laser for fovea-involving diabetic macular edema in eyes with good visual acuity. Retina. 2014;34:2010–2020. doi:10.1097/IAE.0000000000000177
  • Valera-Cornejo DA, García-Roa M, Quiroz-Mendoza J, et al. Micropulse laser in patients with refractory and treatment-naïve center–involved diabetic macular edema: short terms visual and anatomic outcomes. Ther Adv Ophthalmol. 2021;13:251584142097911. doi:10.1177/2515841420979112
  • Passos RM, Malerbi FK, Rocha M, Maia M, Farah ME. Real-life outcomes of subthreshold laser therapy for diabetic macular edema. Int J Retin Vitr. 2021;7. doi:10.1186/s40942-020-00268-3.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.